HCM Q3 2021 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$99M+64.0% YoY

Gross Profit

-$56M-56.5% margin

Operating Income

-$92M-92.9% margin

Net Income

-$46M-46.4% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+31.1%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$70M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$333M

Stockholders' Equity

$987M

Cash & Equivalents

$378M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$61M	+64.0%
Gross Profit	-$56M	-$42M	-32.8%
Operating Income	-$92M	-$59M	-55.8%
Net Income	-$46M	-$38M	-21.3%